Concentrix Corporation

Concentrix (NASDAQ: CNXC) Investor Alert: Johnson Fistel Investigates Following Revenue Outlook Cuts and $1.05 Billion Goodwill Impairment

Johnson Fistel, PLLP, a leading stockholder rights law firm, is investigating Concentrix Corporation (NASDAQ: CNXC) on behalf of investors who may have suffered losses.

Why Is Johnson Fistel Investigating Concentrix?

The investigation concerns whether Concentrix adequately disclosed customer-demand pressures, accelerating offshore migration, customer spending reductions, and their effects on its financial outlook.

Concentrix maintained its fiscal 2026 outlook in March, but reduced its revenue and adjusted earnings forecasts on June 29, 2026, citing faster offshoring and customer spending reductions. Shares fell approximately 24% in premarket trading on June 30.

On September 29, 2026, Concentrix again lowered its revenue outlook and disclosed a $1.05 billion noncash goodwill impairment, primarily attributed to its stock’s trading range and market capitalization. Together with its fiscal 2025 impairment, the charges totaled approximately $2.57 billion.

Johnson Fistel is examining when management knew of these business pressures and whether the Company’s forecasts, disclosures, and goodwill valuation appropriately reflected that information.

About Johnson Fistel, PLLP | Top Law Firm, Securities Fraud, Investor Rights

Johnson Fistel, PLLP is a nationally recognized shareholder rights law firm with offices in California, New York, Georgia, Idaho, and Colorado. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. The firm also represents foreign investors who have purchased securities on U.S. exchanges.

Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.
Johnson Fistel, PLLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content.

Contact:
Johnson Fistel, PLLP
501 W. Broadway, Suite 800
San Diego, CA 92101
James Baker | (619) 814-4471
jimb@johnsonfistel.com